Dr. Levin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
31157 Woodward Ave
Royal Oak, MI 48073Phone+1 248-336-0123Fax+1 248-851-5182
Education & Training
Cleveland Clinic (Florida)Fellowship, Urologic Surgical Oncology, 2016 - 2017
Wayne State University School of MedicineResidency, Urology, 2012 - 2016
Detroit Medical Center CorporationResidency, Surgery, 2011 - 2012
Tel Aviv University SacklerClass of 2011
Certifications & Licensure
MI State Medical License 2011 - 2026
MT State Medical License 2017 - 2019
FL State Medical License 2015 - 2018- American Board of Urology Urology
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- 6 citationsA Diagnostic Test Combining Molecular Testing with Phenotypic Pooled Antibiotic Susceptibility Improved the Clinical Outcomes of Patients with Non-or Polymicrobial Com...Howard J Korman, David Baunoch, Natalie Luke, Dakun Wang, Xihua Zhao
Research and Reports in Urology. 2023-01-01 - Multiplex Polymerase Chain Reaction/Pooled Antibiotic Susceptibility Testing Was Not Associated with Increased Antibiotic Resistance in Management of Complicated Urina...Howard J Korman, Mohit Mathur, Natalie Luke, Dakun Wang, Xihua Zhao
Infection and Drug Resistance. 2023-01-01 - Positive Impact of Implementing a Comprehensive Genetic Testing Protocol for Prostate Cancer Patients in a Multi-disciplinary Uro-oncology Practice.Siddharth Ramanathan, Andrew Korman, Sadhna Ramanathan, Howard Korman, Michael I Ghilezan
Urology Practice. 2023-01-01
Press Mentions
9 Modern Day Dr. FrankensteinsSeptember 6th, 2013
Development of a Surgical Decision Aid for Patients with Nephrolithiasis: Shockwave LithotripsyMarch 27th, 2024- Selective Inhibition of MCL1 Overcomes Venetoclax Resistance in a Murine Model of Myelodysplastic SyndromesApril 2nd, 2024
Professional Memberships
- Member
Other Languages
- Hebrew
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
